214 related articles for article (PubMed ID: 34382324)
1. Deubiquitinase PSMD14 promotes ovarian cancer progression by decreasing enzymatic activity of PKM2.
Sun T; Liu Z; Bi F; Yang Q
Mol Oncol; 2021 Dec; 15(12):3639-3658. PubMed ID: 34382324
[TBL] [Abstract][Full Text] [Related]
2. Deubiquitinase PSMD14 enhances hepatocellular carcinoma growth and metastasis by stabilizing GRB2.
Lv J; Zhang S; Wu H; Lu J; Lu Y; Wang F; Zhao W; Zhan P; Lu J; Fang Q; Xie C; Yin Z
Cancer Lett; 2020 Jan; 469():22-34. PubMed ID: 31634528
[TBL] [Abstract][Full Text] [Related]
3. Deubiquitinating enzyme PSMD14 facilitates gastric carcinogenesis through stabilizing PTBP1.
Li J; Li Y; Xu F; Sun B; Yang L; Wang H
Exp Cell Res; 2022 Jun; 415(2):113148. PubMed ID: 35405117
[TBL] [Abstract][Full Text] [Related]
4. Deubiquitinating enzyme PSMD14 promotes tumor metastasis through stabilizing SNAIL in human esophageal squamous cell carcinoma.
Zhu R; Liu Y; Zhou H; Li L; Li Y; Ding F; Cao X; Liu Z
Cancer Lett; 2018 Apr; 418():125-134. PubMed ID: 29331416
[TBL] [Abstract][Full Text] [Related]
5. Blockade of deubiquitinating enzyme PSMD14 overcomes chemoresistance in head and neck squamous cell carcinoma by antagonizing E2F1/Akt/SOX2-mediated stemness.
Jing C; Duan Y; Zhou M; Yue K; Zhuo S; Li X; Liu D; Ye B; Lai Q; Li L; Yao X; Wei H; Zhang W; Wu Y; Wang X
Theranostics; 2021; 11(6):2655-2669. PubMed ID: 33456565
[TBL] [Abstract][Full Text] [Related]
6. The deubiquitinating enzyme PSMD14 facilitates tumor growth and chemoresistance through stabilizing the ALK2 receptor in the initiation of BMP6 signaling pathway.
Seo D; Jung SM; Park JS; Lee J; Ha J; Kim M; Park SH
EBioMedicine; 2019 Nov; 49():55-71. PubMed ID: 31685442
[TBL] [Abstract][Full Text] [Related]
7. The PSMD14 inhibitor Thiolutin as a novel therapeutic approach for esophageal squamous cell carcinoma through facilitating SNAIL degradation.
Jing C; Li X; Zhou M; Zhang S; Lai Q; Liu D; Ye B; Li L; Wu Y; Li H; Yue K; Chen P; Yao X; Wu Y; Duan Y; Wang X
Theranostics; 2021; 11(12):5847-5862. PubMed ID: 33897885
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of Pyruvate Kinase Type M2 (PKM2) Promotes Ovarian Cancer Cell Growth and Survival Via Regulation of Cell Cycle Progression Related with Upregulated CCND1 and Downregulated CDKN1A Expression.
Zheng B; Liu F; Zeng L; Geng L; Ouyang X; Wang K; Huang Q
Med Sci Monit; 2018 May; 24():3103-3112. PubMed ID: 29752805
[TBL] [Abstract][Full Text] [Related]
9. Deubiquitylase PSMD14 inhibits autophagy to promote ovarian cancer progression via stabilization of LRPPRC.
Zhao Z; Xu H; Wei Y; Sun L; Song Y
Biochim Biophys Acta Mol Basis Dis; 2023 Feb; 1869(2):166594. PubMed ID: 36328147
[TBL] [Abstract][Full Text] [Related]
10. The proteasome component PSMD14 drives myelomagenesis through a histone deubiquitinase activity.
He L; Yu C; Qin S; Zheng E; Liu X; Liu Y; Yu S; Liu Y; Dou X; Shang Z; Wang Y; Wang Y; Zhou X; Liu B; Zhong Y; Liu Z; Lu J; Sun L
Mol Cell; 2023 Nov; 83(22):4000-4016.e6. PubMed ID: 37935198
[TBL] [Abstract][Full Text] [Related]
11. PSMD14 stabilizes estrogen signaling and facilitates breast cancer progression via deubiquitinating ERα.
Yang P; Yang X; Wang D; Yang H; Li Z; Zhang C; Zhang S; Zhu J; Li X; Su P; Zhuang T
Oncogene; 2024 Jan; 43(4):248-264. PubMed ID: 38017133
[TBL] [Abstract][Full Text] [Related]
12. Regulation of Drp1 and enhancement of mitochondrial fission by the deubiquitinating enzyme PSMD14 facilitates the proliferation of bladder cancer cells.
Song W; Li Z; Xia M; Xiao W
Oncol Rep; 2024 Jan; 51(1):. PubMed ID: 37975230
[TBL] [Abstract][Full Text] [Related]
13. Specific Pyruvate Kinase M2 Inhibitor, Compound 3K, Induces Autophagic Cell Death through Disruption of the Glycolysis Pathway in Ovarian Cancer Cells.
Park JH; Kundu A; Lee SH; Jiang C; Lee SH; Kim YS; Kyung SY; Park SH; Kim HS
Int J Biol Sci; 2021; 17(8):1895-1908. PubMed ID: 34131394
[TBL] [Abstract][Full Text] [Related]
14. AKT2 contributes to increase ovarian cancer cell migration and invasion through the AKT2-PKM2-STAT3/NF-κB axis.
Zheng B; Geng L; Zeng L; Liu F; Huang Q
Cell Signal; 2018 May; 45():122-131. PubMed ID: 29374601
[TBL] [Abstract][Full Text] [Related]
15. Follicle-stimulating hormone promoted pyruvate kinase isozyme type M2-induced glycolysis and proliferation of ovarian cancer cells.
Li S; Ji X; Wang R; Miao Y
Arch Gynecol Obstet; 2019 May; 299(5):1443-1451. PubMed ID: 30809696
[TBL] [Abstract][Full Text] [Related]
16. Depletion of PSMD14 suppresses bladder cancer proliferation by regulating GPX4.
Jia C; Zhang X; Qu T; Wu X; Li Y; Zhao Y; Sun L; Wang Q
PeerJ; 2023; 11():e14654. PubMed ID: 36632137
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of Proliferation, Migration, and Invasion by Knockdown of Pyruvate Kinase-M2 (PKM2) in Ovarian Cancer SKOV3 and OVCAR3 Cells.
Miao Y; Lu M; Yan Q; Li S; Feng Y
Oncol Res; 2016 Oct; 24(6):463-475. PubMed ID: 28281967
[TBL] [Abstract][Full Text] [Related]
18. Deubiquitinase PSMD14 promotes tumorigenicity of glioblastoma by deubiquitinating and stabilizing β-catenin.
Wang Y; Liu Y; Ma C; Liu C; Tang Q; Wang Z; Lu J; Chen Z; Wang H
Biofactors; 2024 May; ():. PubMed ID: 38696072
[TBL] [Abstract][Full Text] [Related]
19. Targeting PSMD14 inhibits melanoma growth through SMAD3 stabilization.
Yokoyama S; Iwakami Y; Hang Z; Kin R; Zhou Y; Yasuta Y; Takahashi A; Hayakawa Y; Sakurai H
Sci Rep; 2020 Nov; 10(1):19214. PubMed ID: 33154524
[TBL] [Abstract][Full Text] [Related]
20. HSP90 promotes cell glycolysis, proliferation and inhibits apoptosis by regulating PKM2 abundance via Thr-328 phosphorylation in hepatocellular carcinoma.
Xu Q; Tu J; Dou C; Zhang J; Yang L; Liu X; Lei K; Liu Z; Wang Y; Li L; Bao H; Wang J; Tu K
Mol Cancer; 2017 Dec; 16(1):178. PubMed ID: 29262861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]